Disabilities and Barriers in rare skin disorder

Recognising Disabilities and Barriers in rare skin disorder : key-findings of the Rare barometer  survey

  •  7 / 10 people with rare skin disorders live with disabilities;
  • 66% of respondents have difficulties with at least two of the following activities: seeing, hearing, walking/climbing stairs, remembering/concentrating, selfcare, communicating;
  • 59% find it difficult or very difficult to obtain publicly funded support such as attendant care support, home support, financial support, assistive technology, mobility aids or other support;
  • 52% experienced discrimination related to the rare disease or disability in healthcare, in employment, in education, in housing, in public accommodations and in other places;
  • 14% of people with a rare skin disorder are unemployed (in comparison, the unemployment rate in the general population was 6,1% in the European Union in 2023)

2 RESOLUTIONS AT THE WORLD HEALTH ASSEMBLY

IN GENEVA

21st-22ndMay 2025 :

Marie-Claude Boiteux was  there to support two important resolutions to be voted by the World Health Assembly (WHA).

The first one, presented by Globalskin, is asking for Skin Disorders to be placed as a global public health priority.

The second one, presented by Rare Disease International  for its part, asks for Rare Disorders to be placed as a global public health priority.

Cutis Laxa is a rare and skin disorder. These two resolutions, unanimously voted by WHA in its 24th May 2025 session, are then essential for our patients worldwide.

They open the path to global action plans focused on prevention, early diagnosis, efficient treatment and long term care for all people suffering from rare cutaneous disorders worldwide.

They also promote equitable access to affordable and quality services and integrate skin health in larger healthcare systems.

Healthcare professionals have not been forgotten as the resolutions also call for promoting research on skin disorders in collaboration with academic and research institutions, and for improving data collection, research and monitoring on rare disorders to develop strategies to enhance understanding, timely and confirmed early identification,including screening, diagnosis and treatment options.

We must now carry on working for those Global Action Plans to be implemented and fit with patients’ needs worldwide.

Stakeholders’ National Conference of Dermatology

3rd April 2025 :

Patient organisations representatives met up in Paris to take part in the Stakeholders’ National Conference of Dermatology organised by the French Society of Dermatology (SFD).

Dermatology is facing many issues (i.e. lack of young dermatologists) and all stakeholders must work together, hand in hand, to find solutions for patients to receive the care they deserve.

4th National Plan for Rare Disorders in France

On 25th Février, the 4th National Plan for Rare Disorders was finally launched in France.  Long awaited, but delayed due to the political context, it aims to widen and pursue the work done with the previous Plans. It is based on 4 axes :

  • Improving the life and care pathway (strengthening city-hospital links, strengthening Therapeutic Patient Education, developing specific actions for transition periods, raising awareness, training and informing, mobilizing investigator centers in research);
  • Facilitating and accelerating diagnosis (support “L’Observatoire du Diagnostic” (French statutory organisation promoting diagnostic optimisation), Integrate fetopathology into the patient’s pathway, strengthen foresight in the field of genetics, promote antenatal and neonatal screening, give a diagnosis to each patient, promote new technologies and health data.
  • Promoting access to treatments (strengthen access to innovative treatments, strengthen the development of new therapies, organize real-life data collection for early and compassionate access, support access to therapeutic innovation coordinated with Europe);
  • Developing databases and biobanks (improve the collection and reuse of health data, strengthen biobanks and their use for research purposes, use health databases for research purposes, strengthen the sharing of health data in connection with Europe).

Dermatology-Venerology Meeting

30th-31st  January 2025 :

Dermatology-Venerology Meeting organised in Paris by the National Union of Dermatologists-Venerologists (SNVD).

It gave CLI the opportunity to speak during a round table dedicated to partnerships between patient organisations and SNDV.

And to answer participants’ questions

In the Media

02nd September 2024 

Info-Chalon (newspaper) Official opening of the resource center for tele-expertise in dermatology in Chalon-sur-Saône.

Read the article (in French)

 

10th September 2024

 Le Journal de Saone et Loire (Newspaper) Official opening of the resource center for tele-expertise in dermatology in Chalon-sur-Saône.

Read the article (in French)

 

29th November 2024

Charente Libre  Handing over the € 2,500 check to the benefit of Cutis Laxa Internationale by  Triathlon de Sireuil

Read the article (in French)

 

Autumn 2024

la Gazette Bonsoise Cutis Laxa Internationale, beyond the frontiers of Bons en Chablais

Read the article (in French)

6th Conference of the French Federation for Skin (FFP)

03rd December 2024

6th Conference of the French Federation for Skin (FFP)

This event is unmissable: the opportunity to gather together, evoke the achievements of the year and explore future projects in round-tables and interactive workshops.

It was also the last time I was leading the FFP Conference as my 3 years mandate chairing the FFP has come to its end.

Patient Forum

26th November 2024

Pfizer Patient Forum

Marie-Claude Boiteux participated in a roundtable on  « Minimising obstacles and maximizing impact: key learnings from pilot projects and advice for action”.

World Health Assembly (WHA) Resolution on Rare Diseases

On 30th August 2024, Rare Diseases International (RDI), the Arab Republic of Egypt, the State of Qatar and Spain co-hosted a public webinar on the campaign for a World Health Assembly (WHA) Resolution on Rare Diseases in 2025. The event featured discussions of why such a resolution is critical, what it can provide to people living with a rare disease (PLWRD) regionally and nationally and what needs to be done in order for the campaign to succeed.

Despite recent global advances in recognizing the unmet needs of PLWRD, notably the 2021 UN Resolution on Persons Living with a Rare Disease and their Families, the community still faces a number of significant challenges. In particular, limited access to treatments and care, delayed diagnosis, and elevated financial burden. These struggles are often exacerbated in low- and middle-income countries.

A WHA Resolution on Rare Diseases would help address these challenges by building on the momentum generated by the UN Resolution and instituting a comprehensive, health-focused global framework for rare diseases with clear targets and deadlines for all WHO Member States. The campaign for such a Resolution was initially spearheaded by RDI, with Egypt, Qatar, Spain, Malaysia, and France agreeing to act as co-sponsors. (©orphanews 2024.09.18)

Infographics

 5 % of the global population are suffering from a rare disorder

Equity for people living with a rare disorder means equitable access to diagnosis, treatments, care, social protection and opportunities

300 million people worldwide live with a rare disorder. That is equivalent to the population of the 3rd biggest country.